RxDoctor Payments Data

Connette McMahon, MD

Obstetrics & Gynecology · Fayetteville, NCNPI 1245334499

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (43.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Lupin Inc. at 54.7% of the total. Reporting peaked in 2019 at $3,454 and has fallen 95.2% since, to $166 in 2025.

$4,146in general payments, 2019–2025

Across 54 payments — averaging $76.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lupin Inc.$2K
  • Merck$1K
  • AbbVie$158
  • Astellas Pharma US Inc$141
  • Hologic Sales And Service, LLC$104
  • Novo Nordisk$63
  • plus $397 from 12 others
$436,937in research payments, 2019–2025

Across 178 payments — averaging $2454.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Organon$147K
  • AbbVie$76K
  • GSK$66K
  • Evofem Biosciences, Inc.$61K
  • Abbott$23K
  • Merck$17K
  • plus $47K from 5 others

What the payments were for

  • Speaking & faculty fees$1,00024%
  • Travel & lodging$1,78543%
  • Food & beverage$1,22129%
  • Education$1413%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,146 in reported general payments places this provider in the 85th percentile of 1,344 obstetrics & gynecology providers in North Carolina.

See all obstetrics & gynecology providers in North Carolina

Medicare billing

Part B allowed, 2024
$8,617
Medicare patients
47
Services billed
101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol74$6,627
ValacyclovirValacyclovir Hcl37$1,409
Nystatin31$795
Oxybutynin Chloride ErOxybutynin Chloride34$792
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip24$553
Medroxyprogesterone Acetate19$310
Alendronate Sodium32$228
Ibuprofen28$159
Misoprostol17$111
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide19$80
Alprazolam24$35
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$24

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Fayetteville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →